Peter Ganly
Peter Ganly
Canterbury Health Labs, Christchurch, New Zealand
Потвърден имейл адрес: cdhb.health.nz
Genomic classification and prognosis in acute myeloid leukemia
E Papaemmanuil, M Gerstung, L Bullinger, VI Gaidzik, P Paschka, ...
New England Journal of Medicine 374 (23), 2209-2221, 2016
Oral ixazomib, lenalidomide, and dexamethasone for multiple myeloma
P Moreau, T Masszi, N Grzasko, NJ Bahlis, M Hansson, L Pour, I Sandhu, ...
New England Journal of Medicine 374 (17), 1621-1634, 2016
Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic …
T Robak, A Dmoszynska, P Solal-Céligny, K Warzocha, J Loscertales, ...
Journal of clinical oncology 28 (10), 1756-1765, 2010
p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus.
V Sundaresan, P Ganly, P Hasleton, R Rudd, G Sinha, NM Bleehen, ...
Oncogene 7 (10), 1989-1997, 1992
Precision oncology for acute myeloid leukemia using a knowledge bank approach
M Gerstung, E Papaemmanuil, I Martincorena, L Bullinger, VI Gaidzik, ...
Nature genetics 49 (3), 332-340, 2017
Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial
RA Mesa, AM Vannucchi, A Mead, M Egyed, A Szoke, A Suvorov, ...
The Lancet Haematology 4 (5), e225-e236, 2017
A multicentre, open, non‐comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony‐stimulating factor in relapsed and refractory …
G Jackson, P Taylor, GM Smith, R Marcus, A Smith, P Chu, TJ Littlewood, ...
British journal of haematology 112 (1), 127-137, 2001
Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial
MV Mateos, H Blacklock, F Schjesvold, A Oriol, D Simpson, A George, ...
The Lancet Haematology 6 (9), e459-e469, 2019
A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in …
J Sanders, A Pithie, P Ganly, L Surgenor, R Wilson, E Merriman, ...
Journal of antimicrobial chemotherapy 62 (4), 809-815, 2008
Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients
H Avet-Loiseau, NJ Bahlis, WJ Chng, T Masszi, L Viterbo, L Pour, P Ganly, ...
Blood, The Journal of the American Society of Hematology 130 (24), 2610-2618, 2017
Ixazomib, an investigational oral proteasome inhibitor (PI), in combination with lenalidomide and dexamethasone (IRd), significantly extends progression-free survival (PFS) for …
P Moreau, T Masszi, N Grzasko, NJ Bahlis, M Hansson, L Pour, I Sandhu, ...
Blood 126 (23), 727, 2015
Tissue plasminogen activator for hepatic vein thrombosis in paroxysmal nocturnal haemoglobinuria
MF McMullin, P Hillmen, J Jackson, P Ganly, L Luzzatto
Journal of internal medicine 235 (1), 85-89, 1994
Rituximab, fludarabine, and cyclophosphamide (R-FC) prolongs progression free survival in relapsed or refractory chronic lymphocytic leukemia (CLL) compared with FC alone …
T Robak, SI Moiseev, A Dmoszynska, P Solal-Céligny, K Warzocha, ...
Blood 112 (11), lba-1, 2008
Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia
P Ganly, LC Walker, CM Morris
Leukemia & lymphoma 45 (1), 1-10, 2004
Reduction of exit-site infections of tunnelled intravascular catheters among neutropenic patients by sustained-release chlorhexidine dressings: results from a prospective …
ST Chambers, J Sanders, WN Patton, P Ganly, M Birch, JA Crump, ...
Journal of Hospital Infection 61 (1), 53-61, 2005
A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma
N Bolli, Y Li, V Sathiaseelan, K Raine, D Jones, P Ganly, F Cocito, ...
Blood cancer journal 6 (9), e467-e467, 2016
A novel inherited mutation of the transcription factor RUNX1 causes thrombocytopenia and may predispose to acute myeloid leukaemia
LC Walker, J Stevens, H Campbell, R Corbett, R Spearing, D Heaton, ...
British journal of haematology 117 (4), 878-881, 2002
Successful treatment of acute promyelocytic leukaemia during pregnancy
D Carradice, N Austin, K Bayston, PS Ganly
Clinical & Laboratory Haematology 24 (5), 307-311, 2002
PCR-based RFLP analysis allows genotyping of the short arm of chromosome 3 in small biopsies from patients with lung cancer
PS Ganly, N Jarad, RM Rudd, PH Rabbitts
Genomics 12 (2), 221-228, 1992
Chronic myeloid leukemia in the Asia-Pacific region: current practice, challenges and opportunities in the targeted therapy era
DW Kim, SD Banavali, U Bunworasate, YT Goh, P Ganly, H Huang, ...
Leukemia research 34 (11), 1459-1471, 2010
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20